Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Access to Opioids for Patients with Advanced Disease

Author(s): Helen Edwards* and Michael Bennett

Volume 25, Issue 30, 2019

Page: [3203 - 3208] Pages: 6

DOI: 10.2174/1381612825666190716095337

Price: $65

Abstract

Pain at the end of life is common in both malignant and non-malignant disease. It is feared by patients, their families and careers, and professionals. Effective pain control can be achieved for the majority of patients at the end of life using a multimodal approach. Pharmacological management relies predominantly on strong opioids. In spite of this, evidence suggests that under treatment of pain is common resulting in unnecessary suffering. Multiple barriers to use of opioids have been identified. Patient barriers include reluctance to report pain and to take analgesics. Professional barriers include inadequate pain assessment and lack of specialist knowledge and confidence in opioid therapy. Fear of side effects including respiratory depression affects patients and professionals alike. The impact of the “opioid epidemic”, with increasing prescribed and illicit opioid use around the world, has also led to increasingly stringent regulation and concern about under prescribing in palliative care. System barriers to use of opioids at the end of life result from limited opioid availability in some countries and also inconsistent and limited access to palliative care. Multiple interventions have been developed to address these barriers, targeted at patients, professionals and systems. There is increasing evidence to suggest that complex interventions combining a number of different approaches are most effective in optimising pain outcomes for patients at the end of life.

Keywords: Access to opioids, advanced disease, pain, palliative care, treatment, analgesics.

« Previous Next »
[1]
Association BM. End-of-life care and physician-assisted dying: Volume 2 - Public dialogue research 2016.Available from:. https://www.bma.org.uk/collective-voice/policy-and-research/ethics/end-of-life-care
[2]
van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 2016; 51(6): 1070-1090.e9.
[http://dx.doi.org/10.1016/j.jpainsymman.2015.12.340] [PMID: 27112310]
[3]
Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31(1): 58-69.
[http://dx.doi.org/10.1016/j.jpainsymman.2005.06.007] [PMID: 16442483]
[4]
Moens K, Higginson IJ, Harding R, et al. Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage 2014; 48(4): 660-77.
[http://dx.doi.org/10.1016/j.jpainsymman.2013.11.009] [PMID: 24801658]
[5]
Etkind SN, Bone AE, Gomes B, et al. How many people will need palliative care in 2040? Past trends, future projections and implications for services. BMC Med 2017; 15(1): 102.
[http://dx.doi.org/10.1186/s12916-017-0860-2] [PMID: 28514961]
[6]
Organisation WH. Cancer 2108 [22/10/2018] Available from:. http://www.who.int/news-room/fact-sheets/detail/cancer
[7]
Nations U. 2017 Revision of World Population Prospects 2017.Available from:. https://population.un.org/wpp/Download/Probabilistic/Population/
[8]
Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1459-544.
[http://dx.doi.org/10.1016/S0140-6736(16)31012-1] [PMID: 27733281]
[9]
Changing trends in mortality: an international comparison: 2000 to 2016.Available from:. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/articles/changingtrendsinmortalityaninternationalcomparison/2000to2016
[10]
Organisation WH. Projections of mortality and causes of death, 2015 and 2030 2015 [09/05/2019] 2015.Available from:. http://www.who.int/healthinfo/global_burden_ disease/projections/en/
[11]
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3(11)e442
[http://dx.doi.org/10.1371/journal.pmed.0030442] [PMID: 17132052]
[12]
Bostwick D, Wolf S, Samsa G, et al. Comparing the palliative care needs of those with cancer to those with common non-cancer serious illness. J Pain Symptom Manage 2017; 53(6): 1079-1084.e1.
[http://dx.doi.org/10.1016/j.jpainsymman.2017.02.014] [PMID: 28457746]
[13]
Johnson M, Fallon M. Just good care? The palliative care of those with non-malignant disease. Palliat Med 2013; 27(9): 803-4.
[http://dx.doi.org/10.1177/0269216313504058] [PMID: 24058003]
[14]
Schmidt BL, Hamamoto DT, Simone DA, Wilcox GL. Mechanism of cancer pain. Mol Interv 2010; 10(3): 164-78.
[http://dx.doi.org/10.1124/mi.10.3.7] [PMID: 20539035]
[15]
Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 2018; 29(Suppl. 4): iv166-91.
[16]
Fallon MT. Neuropathic pain in cancer. Br J Anaesth 2013; 111(1): 105-11.
[http://dx.doi.org/10.1093/bja/aet208] [PMID: 23794652]
[17]
Bennett MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain 2012; 153(2): 359-65.
[http://dx.doi.org/10.1016/j.pain.2011.10.028] [PMID: 22115921]
[18]
Romem A, Tom SE, Beauchene M, Babington L, Scharf SM, Romem A. Pain management at the end of life: A comparative study of cancer, dementia, and chronic obstructive pulmonary disease patients. Palliat Med 2015; 29(5): 464-9.
[http://dx.doi.org/10.1177/0269216315570411] [PMID: 25680377]
[19]
Gavazzi A, De Maria R, Manzoli L, et al. Palliative needs for heart failure or chronic obstructive pulmonary disease: results of a multicenter observational registry. Int J Cardiol 2015; 184: 552-8.
[http://dx.doi.org/10.1016/j.ijcard.2015.03.056] [PMID: 25767016]
[20]
HajGhanbari B, Holsti L, Road JD, Darlene Reid W. Pain in people with chronic obstructive pulmonary disease (COPD). Respir Med 2012; 106(7): 998-1005.
[http://dx.doi.org/10.1016/j.rmed.2012.03.004] [PMID: 22531146]
[21]
van Dam van Isselt EF, Groenewegen-Sipkema KH, Spruit-van Eijk M, et al. Pain in patients with COPD: a systematic review and meta-analysis. BMJ Open 2014; 4(9) e005898
[http://dx.doi.org/10.1136/bmjopen-2014-005898] [PMID: 25260370]
[22]
Achterberg WP, Pieper MJC, van Dalen-Kok AH, et al. Pain management in patients with dementia. Clin Interv Aging 2013; 8: 1471-82.
[http://dx.doi.org/10.2147/CIA.S36739] [PMID: 24204133]
[23]
Brennan F, Carr D, Cousins M. Access to pain management-still very much a human right. Pain Med 2016; 17(10): 1785-9.
[http://dx.doi.org/10.1093/pm/pnw222] [PMID: 27738190]
[24]
Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007; 105(1): 205-21.
[http://dx.doi.org/10.1213/01.ane.0000268145.52345.55] [PMID: 17578977]
[25]
Bennett MI. Mechanism-based cancer-pain therapy. Pain 2017; 158(Suppl. 1): S74-8.
[http://dx.doi.org/10.1097/j.pain.0000000000000825] [PMID: 28151836]
[26]
World Health Organisation. Analgesic ladder. Available from:. http://www.who.int/cancer/palliative/painladder/en/
[27]
World Health Organisation. Cancer Pain Relief 1986; 1-79.
[28]
Bennett M. What evidence do we have that the WHO analgesic ladder is effective in cancer pain? Systematic reviews in pain research: Methodology Redefined. 2008.
[29]
British Medical Association. Improving analgesic use to support pain management at the end of life London 2017. [updated 01/10/2018]
[30]
Palliative cancer care – pain 2016 01/10/2018 2018.Available from:. https://cks.nice.org.uk/palliative-cancer-care-pain
[31]
Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review. J Pain Res 2016; 9: 515-34.
[http://dx.doi.org/10.2147/JPR.S97759] [PMID: 27524918]
[32]
Bennett MI, Paice JA, Wallace M. Pain and opioids in cancer care: benefits, risks and alternatives. Am Soc Clin Oncol Educ Book 2017; 37: 705-13.
[33]
Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13(2): e58-68.
[http://dx.doi.org/10.1016/S1470-2045(12)70040-2] [PMID: 22300860]
[34]
Swarm RA, Abernethy AP, Anghelescu DL, et al. Adult cancer pain. J Natl Compr Canc Netw 2013; 11(8): 992-1022.
[http://dx.doi.org/10.6004/jnccn.2013.0119] [PMID: 23946177]
[35]
Palliative care for adults: strong opioids for pain relief 2016 2018.Oct 22. https://www.nice.org.uk/guidance/cg140
[36]
van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007; 18(9): 1437-49.
[http://dx.doi.org/10.1093/annonc/mdm056] [PMID: 17355955]
[37]
Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol 2014; 32(36): 4149-54.
[http://dx.doi.org/10.1200/JCO.2014.56.0383] [PMID: 25403222]
[38]
Ziegler L, Mulvey M, Blenkinsopp A, Petty D, Bennett MI. Opioid prescribing for patients with cancer in the last year of life: a longitudinal population cohort study. Pain 2016; 157(11): 2445-51.
[http://dx.doi.org/10.1097/j.pain.0000000000000656] [PMID: 27626624]
[39]
Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009; 20(8): 1420-33.
[http://dx.doi.org/10.1093/annonc/mdp001] [PMID: 19244085]
[40]
Higginson IJ, Gao W. Opioid prescribing for cancer pain during the last 3 months of life: associated factors and 9-year trends in a nationwide United Kingdom cohort study. J Clin Oncol 2012; 30(35): 4373-9.
[http://dx.doi.org/10.1200/JCO.2012.42.0919] [PMID: 23109701]
[41]
Borgsteede SD, Deliens L, Zuurmond WW, et al. Prescribing of pain medication in palliative care. A survey in general practice. Pharmacoepidemiol Drug Saf 2009; 18(1): 16-23.
[http://dx.doi.org/10.1002/pds.1678] [PMID: 18985638]
[42]
Gagnon B, Scott S, Nadeau L, Lawlor PG. Patterns of community-based opioid prescriptions in people dying of cancer. J Pain Symptom Manage 2015; 49(1): 36-44.e1.
[http://dx.doi.org/10.1016/j.jpainsymman.2014.05.015] [PMID: 24945491]
[43]
Fredheim OM, Brelin S, Hjermstad MJ, et al. Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009. Eur J Pain 2017; 21(3): 530-40.
[http://dx.doi.org/10.1002/ejp.956] [PMID: 27739657]
[44]
Statistics Of N. National Survey of Bereaved People (VOICES) Statistical bulletins 2015.Available from:. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem/bulletins/nationalsurveyofbereavedpeoplevoices/england2015#relief-of-pain-in-the-last-3-months-of-life
[45]
Shipman C, Gysels M, White P, et al. Improving generalist end of life care: national consultation with practitioners, commissioners, academics, and service user groups. BMJ 2008; 337: a1720.
[http://dx.doi.org/10.1136/bmj.a1720] [PMID: 18829640]
[46]
Maltoni M. Opioids, pain, and fear. Ann Oncol 2008; 19(1): 5-7.
[http://dx.doi.org/10.1093/annonc/mdm555] [PMID: 18073220]
[47]
Agency for Healthcare Policy and Research. Management of Cancer Pain: Adults. Quick Reference Guide Number 9. 1994.[Cited 11/10/2018] Available from:. https://www.ncbi.nlm.nih.gov/books/NBK52131/
[48]
Gardiner C, Gott M, Ingleton C, Hughes P, Winslow M, Bennett MI. Attitudes of health care professionals to opioid prescribing in end-of-life care: a qualitative focus group study. J Pain Symptom Manage 2012; 44(2): 206-14.
[http://dx.doi.org/10.1016/j.jpainsymman.2011.09.008] [PMID: 22672918]
[49]
Gott M, Gardiner C, Small N, et al. The effect of the Shipman murders on clinician attitudes to prescribing opiates for dyspnoea in end-stage chronic obstructive pulmonary disease in England. Prog Palliat Care 2010; 18(2): 79-84.
[http://dx.doi.org/10.1179/096992610x12624290276700]
[50]
Shipman JS. Shipman: the final report 2005 [09/05/2019] 2005.Available from:. http://webarchive.nationalarchives.gov.uk/20090808155005/http://www.the-shipman-inquiry.org.uk/home.asp
[51]
Jones J. Gosprt War Memorial Hospital:. the report of the Gosport Indendent Panel. Report no HC 1084 2018.
[52]
Oldenmenger WH, Sillevis Smitt PA, van Dooren S, Stoter G, van der Rijt CC. A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal. Eur J Cancer 2009; 45(8): 1370-80.
[http://dx.doi.org/10.1016/j.ejca.2009.01.007] [PMID: 19201599]
[53]
Kwon JH. Overcoming barriers in cancer pain management. J Clin Oncol 2014; 32(16): 1727-33.
[http://dx.doi.org/10.1200/JCO.2013.52.4827] [PMID: 24799490]
[54]
Ward S, Hughes S, Donovan H, Serlin RC. Patient education in pain control. Support Care Cancer 2001; 9(3): 148-55.
[http://dx.doi.org/10.1007/s005200000176] [PMID: 11401098]
[55]
López-Saca JM, Guzmán JL, Centeno C. A systematic review of the influence of opioids on advanced cancer patient survival. Curr Opin Support Palliat Care 2013; 7(4): 424-30.
[http://dx.doi.org/10.1097/SPC.0b013e328365763a] [PMID: 24145680]
[56]
Department BMAE. Medical Ethics Today: In: The BMA's Handbook of Ethics and Law London. Wiley-Blackwell/BMJ Books 2012.
[57]
Macauley R. The role of the principle of double effect in ethics education at US medical schools and its potential impact on pain management at the end of life. J Med Ethics 2012; 38(3): 174-8.
[http://dx.doi.org/10.1136/medethics-2011-100105] [PMID: 21947800]
[58]
Weisberg DF, Becker WC, Fiellin DA, Stannard C. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons. Int J Drug Policy 2014; 25(6): 1124-30.
[http://dx.doi.org/10.1016/j.drugpo.2014.07.009] [PMID: 25190034]
[59]
Opioid Consumption Data Available from. http://www.painpolicy. wisc.edu/opioid-consumption-data [Accessed on 22/10/2018]
[60]
Rauenzahn S, Del Fabbro E. Opioid management of pain: the impact of the prescription opioid abuse epidemic. Curr Opin Support Palliat Care 2014; 8(3): 273-8.
[http://dx.doi.org/10.1097/SPC.0000000000000065] [PMID: 25004173]
[61]
Dowell D, Haegerich TM, Chou R. CDC Guideline for prescribing opioids for chronic pain-United States, 2016. JAMA 2016; 315(15): 1624-45.
[http://dx.doi.org/10.1001/jama.2016.1464] [PMID: 26977696]
[62]
Cherny NI, Cleary J, Scholten W, Radbruch L, Torode J. The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology. Ann Oncol 2013; 24(Suppl. 11): xi7-xi13.
[63]
WHO Model List of Essential Medicines [Internet] 2017. [cited 15/10/2018] Available from:. http://apps.who.int/iris/bitstream/handle/10665/273826/EML-20-eng.pdf?ua=1
[64]
Cherny NI, Baselga J, de Conno F, Radbruch L. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol 2010; 21(3): 615-26.
[http://dx.doi.org/10.1093/annonc/mdp581] [PMID: 20176694]
[65]
British Medical Association. Palliative Care 2018.Available from:. http://www.who.int/news-room/fact-sheets/detail/palliative-care
[66]
Harrison N, Cavers D, Campbell C, Murray SA. Are UK primary care teams formally identifying patients for palliative care before they die? Br J Gen Pract 2012; 62(598): e344-52.
[http://dx.doi.org/10.3399/bjgp12X641465] [PMID: 22546594]
[67]
Allsop MJ, Ziegler LE, Mulvey MR, Russell S, Taylor R, Bennett MI. Duration and determinants of hospice-based specialist palliative care: A national retrospective cohort study. Palliat Med 2018; 32(8): 1322-33.
[http://dx.doi.org/10.1177/0269216318781417] [PMID: 29874525]
[68]
Bennett MI, Bagnall A-M, José Closs S. How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. Pain 2009; 143(3): 192-9.
[http://dx.doi.org/10.1016/j.pain.2009.01.016] [PMID: 19285376]
[69]
Oldenmenger WH, Geerling JI, Mostovaya I, et al. A systematic review of the effectiveness of patient-based educational interventions to improve cancer-related pain. Cancer Treat Rev 2018; 63: 96-103.
[http://dx.doi.org/10.1016/j.ctrv.2017.12.005] [PMID: 29272781]
[70]
Allsop MJ, Wright-Hughes A, Black K, et al. Improving the management of pain from advanced cancer in the community: study protocol for a pragmatic multicentre randomised controlled trial. BMJ Open 2018; 8(3) e021965
[http://dx.doi.org/10.1136/bmjopen-2018-021965]
[71]
Kroenke K, Theobald D, Wu J, et al. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA 2010; 304(2): 163-71.
[http://dx.doi.org/10.1001/jama.2010.944] [PMID: 20628129]
[72]
Oldenmenger WH, Sillevis Smitt PA, van Montfort CA, de Raaf PJ, van der Rijt CC. A combined pain consultation and pain education program decreases average and current pain and decreases interference in daily life by pain in oncology outpatients: a randomized controlled trial. Pain 2011; 152(11): 2632-9.
[http://dx.doi.org/10.1016/j.pain.2011.08.009] [PMID: 21906879]
[73]
Ziegler L, Bennett MI, Mulvey M, Hamilton T, Blenkinsopp A. Characterising the growth in palliative care prescribing 2011-2015: Analysis of national medical and non-medical activity. Palliat Med 2018; 32(4): 767-74.
[http://dx.doi.org/10.1177/0269216317739805] [PMID: 29130384]

Rights & Permissions Print Cite
Article Metrics
23
5
1
1
© 2024 Bentham Science Publishers | Privacy Policy